The confidence of dual-target detection
Molecular testing by polymerase chain reaction (PCR) technology is regarded as the most sensitive method of direct detection for Herpes Simplex Virus (HSV) 1 and 2.1
The cobas® HSV 1 and 2 test for use on the cobas® 4800 System utilizes a dual-target approach to ensure accurate identification of HSV-1 and HSV-2 from genital lesions.
Reliable identification with optimized sensitivity and specificity
Compared to a CE- and FDA-cleared nucleic acid amplification test (NAAT), cobas® HSV 1 and 2 delivers high sensitivity and specificity in the direct detection of HSV-1 and HSV-2 DNA in clinical specimens.*